From a trickle just a few years ago, AI use in the patent profession has become a rushing torrent. AI tools, features, and ...

We're also trying to make sure we look back at some of the trades that are still alive so we can keep you posted. We wrote ...

The measure of progress will be how effectively increased filings translate into productive technologies and economic value.

In healthcare, Hims & Hers shares surged after Novo Nordisk dropped a patent lawsuit and struck a distribution deal. Meanwhile, Bitcoin held near $69,000, showing resilience despite volatility across ...

Vibe coding is fast, but can create ownership, confidentiality and vulnerability issues. Ballard Spahr attorneys share steps to reduce exposure before you ship.

Wall Street is turning constructive on three clinical-stage biotechs simultaneously, each sitting at the edge of a binary catalyst. The analyst calls on uniQure (NASDAQ:QURE), Syndax Pharmaceuticals ...

Market experts also say India must move from being a processor economy to owning products, platforms and innovation.

Lead candidate, EDIT-401, which demonstrated >90% mean LDL-C reduction in preclinical studies, remains on track for IND/CTA submission by mid-2026 Preparing to initiate Company's first-in-human clinic ...

Lead candidate, EDIT-401, which demonstrated >90% mean LDL-C reduction in preclinical studies, remains on track for IND/CTA submission by mid-2026 ...

The therapy, mezigdomide, is part of group of medicines the pharma sees as successors to its lucrative multiple myeloma drugs ...

PARIS, FRANCE, 09 March 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that it is voluntarily withdrawing Tazverik (tazemetostat) in all indications from all Ipsen markets. Ipsen's decision ...

Niraparib and abiraterone acetate regimen demonstrates clinically meaningful delay in disease progression, nearly halving the risk of progression or death, with an early trend toward improved overall ...